Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors

By Varuni Kondagunta G.   Bacik Jennifer   Schwartz Lawrence   Sheinfeld Joel   Bajorin Dean   Vuky Jacqueline   Marion Stephanie   Mazumdar Madhu   Bosl George J.   Motzer Robert J.  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 177-179

Springer Publishing Company

Access to resources Recommend Favorite

Combined treatment with gemcitabine plus oxaliplatin shows encouraging efficacy in patients with relapsed or cisplatin-refractory germ cell tumours

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Phase 1 trial of Anvirzel™ in patients with refractory solid tumors

By Mekhail Tarek   Kaur Hanspreet   Ganapathi Ram   Budd G.   Elson Paul   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 423-427

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial

By Reynolds Craig   Spira Alexander   Gluck Larry   Bradie-Muller Suzanne   Zhan Feng   Boehm Kristi   Asmar Lina  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1628-1628

Springer Publishing Company

Access to resources Recommend Favorite

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3435-3443

Blackwell Publishing

Access to resources Recommend Favorite